T1	Participants 318 351	non-erosive reflux disease (NERD)
T2	Participants 1006 1206	398 patients were recruited in the initial therapy group, among whom 253 were included in on-demand therapy, with 127 patients in the hydrotalcite group and the remaining 126 in the esomeprazole group
T3	Participants 1654 1667	NERD patients
